2 models fit Centrus Energy Corp. Class A Common Stock and they agree: 2 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
ACCE opinionCentrus Energy Corp. Class A Common Stock (LEU)
Fair value (2 models)
$54.59
ACCE price target
$83.00
Rating
Overvalued
Horizon
12 months
Fair value published on 21 Oct 2026, 11:06 CEST; previously $57.02 since 16 Oct 2026, 00:00 CEST.
ACCE price target published on 23 Oct 2026, 01:52 CEST; previously $126 since 11 Oct 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 15:05 CEST.
Price used: $102 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
87.7% above
-46.7% to fair value
ACCE score
32
out of 100
Analysts
63% buy
19 covering
P/E
48.7x
forward 114.9x
1-year return
-70.2%
Dividend yield
0.00%
Centrus Energy Corp. Class A Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Centrus Energy supplies enriched uranium fuel for commercial nuclear reactors, operating the Piketon, Ohio enrichment facility and the American Centrifuge technology behind it, and it is one of very few US suppliers able to produce high-assay low-enriched uranium, a product that Western reactor designers increasingly need. The structural case rests on that scarcity: enrichment capacity is slow and expensive to build, and the company is one of the few domestic sources that can meet US government demand under long-term contracts. Revenue grew 14.0% over the trailing period, but the margin profile is thin, with a 23.7% gross margin and only a 5.3% operating margin, and ROE of 8.1% gives little evidence yet that growth is converting into shareholder returns. At 59.4 times trailing earnings and 114.9 times forward earnings, the stock is pricing in a sharp earnings ramp that the forward multiple implies is not yet visible in current estimates. The composite score of 29/100 and the absence of index membership point to a name that screens poorly on current fundamentals despite the policy tailwind, so the deeper look should focus on whether the enrichment contracts and the timing of the high-assay buildout can close that gap.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
high
Earnings collapsing year over year
Earnings are down 51.6% YoY and 47.5% QoQ while revenue grew 14.0%, so margins are shrinking even as sales rise. A P/E of 53.7 leaves little room for further earnings decline.
high
Heavy short interest
Short interest stands at 30.3% of the float, a level that signals strong bearish conviction among informed sellers and can amplify volatility in either direction.
moderate
Leveraged balance sheet
Debt/Equity of 1.59 with free cash flow of only $31M gives limited cushion if earnings keep falling.
AI research notes
AI-assisted·How I use AIWritten Oct 20, 2026 · figures from 2026-10-20 · prices to Oct 23, 2026
Why it could do well
Revenue grew 14.0% year over year and has averaged 12.7% annual growth over five years, a steady pace for a business in this sector.
Analysts rate the stock Buy or Strong Buy at 63% (12 of 19), and their mean price target sits well above today's share price.
Latest quarterly earnings beat expectations, with earnings per share of 0.77 against 0.74 expected, a surprise of 4.1%.
Why it could disappoint
At a forward P/E of 114.9x against a sector median of 16.1x, investors are paying a large premium for future earnings.
Free cash flow yield is only 1.3%, and the diluted share count rose 21.7% last year, diluting existing shareholders.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where LEU's valuation models land
Price
$102.45
Model fair value
$54.59
Model range
$54.18 to $54.94
Fair value $54.59
Price $102
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores